Literature DB >> 11010605

Health-related quality of life in asymptomatic patients with HIV. Evaluation of the SF-36 health survey in Italian patients.

F Arpinelli1, G Visonà, R Bruno, G De Carli, G Apolone.   

Abstract

OBJECTIVE: To investigate the psychometric performance and clinical validity of the 36-Item Short Form (SF-36) health survey when completed by asymptomatic HIV-positive Italian patients and to compare their health profile with a representative sample of 2031 Italian citizens (the Italian norm). PATIENTS AND METHODS: This was an observational, multicentre, cross-sectional survey. Microbiologists throughout Italy recruited asymptomatic HIV-positive individuals who were aged at least 18 years and aware of their infection. Investigators collected demographic, social, clinical and treatment data. Patients, classified into 2 clinical categories (A1 and A2) according to explicit pre-defined criteria, completed the SF-36 health survey in the context of a medical visit.
RESULTS: Between April and July 1996, 46 microbiologists recruited 214 patients (201 evaluable). No inconsistent responses were observed in 96% of the sample. The usually recommended psychometric standards were satisfied, and the internal consistency reliability indices were always greater than 0.70. Weak to moderate associations were found between SF-36 health survey scores and physicians' estimates of patients' physical performance, while no significant associations were found with CD4+ counts. On average, HIV-positive patients reported lower scores than the Italian norm, and patients in category A2 showed lower scores than patients in A1. These differences were more relevant in scales describing role limitations, general health perception, and psychological well-being.
CONCLUSION: Our study showed that the SF-36 health survey maintained its psychometric properties in a sample of Italian asymptomatic HIV-positive patients and produced data that showed its validity and robustness in such a setting.

Entities:  

Mesh:

Year:  2000        PMID: 11010605     DOI: 10.2165/00019053-200018010-00007

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  19 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  The problem of quality of life in medicine.

Authors:  A Leplège; S Hunt
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment.

Authors:  S D Keller; J E Ware; B Gandek; N K Aaronson; J Alonso; G Apolone; J B Bjorner; J Brazier; M Bullinger; S Fukuhara; S Kaasa; A Leplège; R W Sanson-Fisher; M Sullivan; S Wood-Dauphinee
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

5.  Defining and measuring quality of life in medicine.

Authors:  G Apolone
Journal:  JAMA       Date:  1998-02-11       Impact factor: 56.272

6.  Summary and recommendations for future research.

Authors:  R A Berzon; A P Leplège; K N Lohr; W R Lenderking; A W Wu
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

7.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.

Authors:  I B Wilson; P D Cleary
Journal:  JAMA       Date:  1995-01-04       Impact factor: 56.272

8.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

9.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

Review 10.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

View more
  16 in total

1.  Quality of life and psychosocial functioning of HIV infected children.

Authors:  Sebi Das; Aparna Mukherjee; Rakesh Lodha; Manju Vatsa
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

2.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

Review 3.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  HRQoL in HIV-infected children using PedsQL 4.0 and comparison with uninfected children.

Authors:  Tanushree Banerjee; Tripti Pensi; Dipankar Banerjee
Journal:  Qual Life Res       Date:  2010-04-10       Impact factor: 4.147

5.  Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease.

Authors:  Giovanna Pasculli; Francesco Resta; Edoardo Guastamacchia; Leonardo Di Gennaro; Patrizia Suppressa; Carlo Sabbà
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

6.  Quality of life among perinatally HIV-affected and HIV-unaffected school-aged and adolescent Ugandan children: a multi-dimensional assessment of wellbeing in the post-HAART era.

Authors:  A K Nkwata; S K Zalwango; F N Kizza; J N Sekandi; J Mutanga; M Zhang; P M Musoke; A E Ezeamama
Journal:  Qual Life Res       Date:  2017-05-22       Impact factor: 4.147

7.  Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.

Authors:  S Trippoli; M Vaiani; C Lucioni; A Messori
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Validity and reliability of the Italian translation of the MOS-HIV health survey in persons with AIDS.

Authors:  Patrizia Schifano; Piero Borgia; Albert W Wu; Teresa Spadea; Giuseppe Milanese; Carlo A Perucci
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

Review 9.  Health-related quality of life assessment after antiretroviral therapy: a review of the literature.

Authors:  Harleen Gakhar; Amanda Kamali; Mark Holodniy
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

10.  Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women.

Authors:  Thiago S Torres; Linda J Harrison; Alberto M La Rosa; Sandra W Cardoso; Lu Zheng; McNeil Ngongondo; Fatma Some; Umesh G Lalloo; Thando Mwelase; Ann C Collier; Michael D Hughes
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.